NK cells in many solid tumors including breast, lung, and liver cancers show increased expression of NKG2A, and likewise HLA-E is frequently increased in melanoma and cancers of the lung, kidney, liver, prostate, and colon [27, 29]. The gene discussed is KLRC1; the disease is liver cancer.